Source: Annual Congress 2003 - From biopsy to treatment of diffuse lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Tazawa, O. Ishimoto, H. Ohta, T. Suzuki, M. Maemondo, M. Ebina, K. Hagiwara, K. Nakata, T. Nukiwa (Sendai, Tokyo, Japan). Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis. Eur Respir J 2003; 22: Suppl. 45, 2442

Member's Comments

No comment yet.

Related content which might interest you: Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis Source: Eur Respir J 2006; 27: 585-593 Year: 2006 Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP) Source: Eur Respir J 2001; 18: Suppl. 33, 221s Year: 2001 Plasmapheresis for treatment of pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1220-1222 Year: 2009 Rituximab therapy in autoimmune pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1503-1506 Year: 2009 Treatment of severe pulmonary alveolar proteinosis using inhaled GM-CSF Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Successful treatment by GMCSF of pulmonary alveolar proteinosis relapsing after a first GMCSF course Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Treatment of pulmonary alveolar proteinosis (PAP) with administration of GM-CSF Source: Eur Respir J 2002; 20: Suppl. 38, 447s Year: 2002 Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis Source: Short video statement 2020 Year: 2020 Inhaled granulocyte–macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis Source: Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017 Year: 2018 Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD Source: Eur Respir J 2008; 32: 25-34 Year: 2008 Alveolar lipoproteinosis syndromes Source: Eur Respir Mon 2011; 54: 171-186 Year: 2011 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation Source: Eur Respir J 2013; 41: 433-442 Year: 2013 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020 Year: 2021 Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 777-780 Year: 2012 Inhaled GM-CSF in pulmonary alveolar proteinosis (PAP) patient refractory to plasmapheresis combined with multiple whole lung lavages (WLL) Source: International Congress 2016 – Orphan diseases I Year: 2016 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Increased vascular endothelial growth factor in acute eosinophilic pneumonia Source: Eur Respir J 2003; 21: 774-778 Year: 2003 Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells Source: Eur Respir J 2001; 17: 1070-1077 Year: 2001